Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:31 PM
Ignite Modification Date:
2025-12-24 @ 1:31 PM
NCT ID:
NCT05859295
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older at enrollment
* Individuals with mild to moderate meibomian gland dysfunction based on clinical signs, e.g., meibum quality score of 1-3, meibography score of 1, 2, or 3 on the Pult Meiboscale, non-invasive 1st tear break up time of 10 seconds or less, or an Ocular Surface Disease Index (OSDI) score of 13 to 32 points
Exclusion Criteria:
* History of systemic disease associated with aqueous-deficient dry eye disease (e.g., Sjogren's syndrome)
* History of corneal surgery, refractive surgery, eyelid surgery or ocular trauma within 6 months
* History of LipiFlow, iLux, Meiboflow, Intense Pulsed Light (IPL) or low level light therapy (LLLT) within the last 12 months
* Use of photosensitizing medications
* Pregnant and/or lactating females
* Pigmented lesions, tattoos, or skin cancer in the periocular region
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05859295
Study Brief:
Protocol Section:
NCT05859295